The CDC in the United States looked at the risk assessment and management of COVID-19 among travellers arriving at designated US airports between January 17 and September 13, 2020. This was an article published on November 13 by Phillip Dollard and others. Research...
Pfizer-BioNTech announced last week that the efficacy portion of their COVID-19 vaccine trial had been completed. The vaccine prevented 95% of cases of the disease. Professor Stebbings in his daily report evaluated results and suggested that they looked a bit better...
An article published November 12 in The Lancet Respiratory Medicine by Monk and others looked at the efficacy and safety of inhaled nebulised interferon beta-1a for the treatment of patients admitted to hospital with COVID-19. They did a randomised, double blind,...
An interesting article published in The Journal of the American Medical Association open network by Sarah Kreps and others in November 2020 looked at this key point. They argued that widespread public uptake of the vaccine is crucial to stem the pandemic and examined...
An interesting article published by Lelieveld and others in the International Journal of Environmental Research and Public Health looked at this vexing issue. Their results substantiated that airborne transmission in the indoor environment is an important factor. They...
An interesting article published in The Lancet by Taquet and others November 9, 2020 look at the adverse mental health consequences of COVID-19, including anxiety and depression to evaluate whether there was an increased psychiatric risk from infection. They studied...
